Related Experiment Video
Updated: May 14, 2026

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
Published on: November 11, 2020
Distribution and deposition of respirable PLGA microspheres in lung alveoli
Keiji Hirota1, Tadafumi Kawamoto, Takehisa Nakajima
1Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan.
Abstract:
Although treatment of pulmonary tuberculosis with respirable microspheres (MS) with an incorporated antituberculosis drug is expected to be highly effective, this treatment seems to achieve a much lesser effect than expected in the case of killing Mycobacterium tuberculosis residing in the lungs. To elucidate the reason for this weaker effect, we examined the distribution and accumulation of respirable MS consisting of poly(lactic-co-glycolic) acid (PLGA) in rat lungs. For this, we delivered the PLGA MS containing fluorescent coumarin 6 or an antituberculosis agent, rifampicin (RFP), by insufflation via the trachea and then determined the pulmonary distribution by counting the number of the MS in lung cryosections observed under a microscope. In addition, the uptake of MS by alveolar macrophage (AMφ) was determined by immunostaining for Mφ cell marker CD68 and RFP content in the cells. Approximately half of the fluorescent PLGA MS reached the alveoli without entrapment by trachea and primary bronchi and were then ingested by the AMφ cells up to 24h after insufflation. RFP in a form of PLGA MS was markedly transported into AMφ at an amount 10 times greater than that for the free RFP powder. However, a large proportion of RFP was eliminated from the lungs by 6h after insufflation.
Insights
Respirable microspheres (MS) for tuberculosis treatment effectively deliver drugs to lung macrophages but show rapid drug elimination, limiting efficacy. Further research is needed to optimize drug release and improve tuberculosis treatment outcomes.
Area of Science:
- Pulmonary drug delivery
- Tuberculosis treatment
- Biomaterials science
Background:
- Pulmonary tuberculosis treatment with microspheres (MS) is expected to be effective.
- However, the actual efficacy against Mycobacterium tuberculosis in the lungs is lower than anticipated.
Purpose of the Study:
- To investigate the distribution and accumulation of poly(lactic-co-glycolic) acid (PLGA) MS in rat lungs.
- To understand the reasons for the reduced efficacy of MS-based antituberculosis drug delivery.
Main Methods:
- PLGA MS containing fluorescent coumarin 6 or rifampicin (RFP) were delivered via tracheal insufflation in rats.
- Pulmonary distribution was assessed by microscopy of lung cryosections.
- Uptake by alveolar macrophages (AMφ) was evaluated using CD68 staining and RFP quantification.
Main Results:
- Around 50% of fluorescent PLGA MS reached the alveoli and were ingested by AMφ within 24 hours.
- PLGA MS significantly increased rifampicin uptake by AMφ (10-fold higher than free RFP).
- A substantial amount of rifampicin was eliminated from the lungs within 6 hours post-insufflation.
Conclusions:
- PLGA MS are efficiently delivered to rat lung alveoli and macrophages.
- While MS enhance drug uptake by macrophages, rapid drug elimination limits sustained therapeutic levels.
- Optimizing drug release kinetics from MS is crucial for improving tuberculosis treatment effectiveness.
Related Concept Videos
Alveoli and Alveolar Ducts
Breathing
The Respiratory System
External and Internal Respiration

